Cleared Traditional

K090104 - LIAISON 25 OH VITAMIN D TOTAL CALIBRATI...

K090104 is the FDA 510(k) clearance for LIAISON 25 OH VITAMIN D TOTAL CALIBRATI... by DiaSorin, Inc.. It is a Class 1 Chemistry device (product code JJX) cleared through the Traditional 510(k) pathway after a 237-day FDA review.

K090104 · DiaSorin, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2009
Decision
237d
Days
Class 1
Risk

K090104 is an FDA 510(k) clearance for the LIAISON 25 OH VITAMIN D TOTAL CALIBRATION VERIFIERS, MODEL: 310603. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by DiaSorin, Inc. (Stillwater, US). The FDA issued a Cleared decision on September 9, 2009 after a review of 237 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all DiaSorin, Inc. devices

Submission Details

510(k) Number K090104 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 15, 2009
Decision Date September 09, 2009
Days to Decision 237 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
149d slower than avg
Panel avg: 88d · This submission: 237d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 370
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K090104.
OMNIS HEALTH EMBRACE GLUCOSE CONTROL SOLUTION
K091914 · Bionostics, Inc. · Nov 2009
ELECSYS RUBELLA IGGA CALCHECK 5
K092585 · Roche Diagnostics · Oct 2009
ELECYS ANTI-CCP CALCHECK
K091601 · Roche Diagnostics Corp. · Sep 2009
FDI GLUCOSE CONTROL LEVELS 1, 2 AND 3
K092645 · Fujirebio Diagnostics,Inc. · Sep 2009
ADVIA CENTAUR DHEAS MASTER CURVE MATERIALS
K091123 · Siemens Healthcare Diagnostics · Aug 2009
ELECSYS RUBELLA IGG CALCHECK
K090311 · Roche Diagnostics · May 2009